Method of Treating Endometrial Tissue Disease by Altering an Epithelial to Mesenchymal Transition
    81.
    发明申请
    Method of Treating Endometrial Tissue Disease by Altering an Epithelial to Mesenchymal Transition 审中-公开
    通过改变上皮细胞向间质转移治疗子宫内膜组织病的方法

    公开(公告)号:US20160250234A1

    公开(公告)日:2016-09-01

    申请号:US15141964

    申请日:2016-04-29

    申请人: Hans M. Albertsen

    发明人: Hans M. Albertsen

    IPC分类号: A61K31/65 A61K31/4412

    摘要: The present invention is a method of treating endometrial tissue disease and in particular a method of treating endometriosis and adenomyosis by administering an Epithelial-to-mesenchymal transition altering compound. The compound may be a natural compound or a synthetic compound. The compound may be in pill form, liquid form, or suppository form.

    摘要翻译: 本发明是一种治疗子宫内膜组织疾病的方法,特别是通过施用上皮 - 间质转化改变化合物治疗子宫内膜异位和子宫腺肌症的方法。 该化合物可以是天然化合物或合成化合物。 该化合物可以是丸剂形式,液体形式或栓剂形式。

    Pharmaceutical composition on the basis of phyto-nutrients with increased bioavailability, having anti-tumor activity, and method for producing said composition (alternatives)
    82.
    发明授权
    Pharmaceutical composition on the basis of phyto-nutrients with increased bioavailability, having anti-tumor activity, and method for producing said composition (alternatives) 有权
    基于具有增加的生物利用度的植物营养素,具有抗肿瘤活性的药物组合物和用于生产所述组合物的方法(备选方案)

    公开(公告)号:US09393230B2

    公开(公告)日:2016-07-19

    申请号:US14435846

    申请日:2013-07-19

    摘要: A pharmaceutical composition for peroral delivery of phyto-nutrients includes at least one phyto-nutrient from the following series: epigallocatechin-3-gallate, diindolylmethane, genestein, resveratrol, curcumine, and a solubilizer—a polyvinylcaprolactam/polyvinylacetate/polyethyleneglycol graft copolymer with an average molecular mass of 90000-140000 g/mol at a mass ratio of at least one phyto-nutrient and solubilizer of 1/5 to 1/1. The composition can additionally include a pharmaceutically acceptable carrier. The composition may be produced by dissolving the solubilizer in an organic solvent, dissolving at least one phyto-nutrient in the same organic solvent, mixing the resulting solutions, and distilling off the solvent in vacuo. The resulting mixture is heated to 45-50° C. with constant stirring and, after distillation, the product is dried in vacuo. Ethanol, acetone, or isopropanol can be used as the organic solvent. Alternatively, the composition may be produced by dry mixing the powders of the solubilizer and of at least one phyto-nutrient.

    摘要翻译: 用于口服递送植物营养物质的药物组合物包括至少一种以下系列的植物营养素:表没食子儿茶素-3-没食子酸酯,二吲哚基甲烷,依那斯汀,白藜芦醇,姜黄素和增溶剂 - 聚乙烯基己内酰胺/聚乙酸乙烯酯/聚乙二醇接枝共聚物, 至少一种植物营养素和增溶剂的质量比为1/5至1/1的平均分子量为90000-140000g / mol。 该组合物可另外包括药学上可接受的载体。 组合物可以通过将增溶剂溶解在有机溶剂中,将至少一种植物营养物溶解在相同的有机溶剂中,混合所得溶液并真空蒸馏除去溶剂来制备。 将所得混合物在恒定搅拌下加热至45-50℃,蒸馏后,将产物真空干燥。 可以使用乙醇,丙酮或异丙醇作为有机溶剂。 或者,可以通过将增溶剂和至少一种植物营养物的粉末干混合来制备组合物。

    PHARMACEUTICAL COMPOSITION ON THE BASIS OF PHYTO-NUTRIENTS WITH INCREASED BIOAVAILABILITY, HAVING ANTI-TUMOR ACTIVITY, AND METHOD FOR PRODUCING SAID COMPOSITION (ALTERNATIVES)
    90.
    发明申请
    PHARMACEUTICAL COMPOSITION ON THE BASIS OF PHYTO-NUTRIENTS WITH INCREASED BIOAVAILABILITY, HAVING ANTI-TUMOR ACTIVITY, AND METHOD FOR PRODUCING SAID COMPOSITION (ALTERNATIVES) 有权
    具有增加的生物可利用性,具有抗肿瘤活性的生物营养物质的基础上的药物组合物和用于生产合成组合物的方法(替代物)

    公开(公告)号:US20150265575A1

    公开(公告)日:2015-09-24

    申请号:US14435846

    申请日:2013-07-19

    摘要: A pharmaceutical composition for peroral delivery of phyto-nutrients includes at least one phyto-nutrient from the following series: epigallocatechin-3-gallate, diindolylmethane, genestein, resveratrol, curcumine, and a solubilizer—a polyvinylcaprolactam/polyvinylacetate/polyethyleneglycol graft copolymer with an average molecular mass of 90000-140000 g/mol at a mass ratio of at least one phyto-nutrient and solubilizer of 1/5 to 1/1. The composition can additionally include a pharmaceutically acceptable carrier. The composition may be produced by dissolving the solubilizer in an organic solvent, dissolving at least one phyto-nutrient in the same organic solvent, mixing the resulting solutions, and distilling off the solvent in vacuo. The resulting mixture is heated to 45-50° C. with constant stirring and, after distillation, the product is dried in vacuo. Ethanol, acetone, or isopropanol can be used as the organic solvent. Alternatively, the composition may be produced by dry mixing the powders of the solubilizer and of at least one phyto-nutrient.

    摘要翻译: 用于口服递送植物营养物的药物组合物包括至少一种下列系列的植物营养素:表没食子儿茶素-3-没食子酸酯,二吲哚基甲烷,依那斯汀,白藜芦醇,姜黄素和增溶剂 - 聚乙烯基己内酰胺/聚乙酸乙烯酯/聚乙二醇接枝共聚物,其具有 至少一种植物营养素和增溶剂的质量比为1/5至1/1的平均分子量为90000-140000g / mol。 该组合物可另外包括药学上可接受的载体。 组合物可以通过将增溶剂溶解在有机溶剂中,将至少一种植物营养物溶解在相同的有机溶剂中,混合所得溶液并真空蒸馏除去溶剂来制备。 将所得混合物在恒定搅拌下加热至45-50℃,蒸馏后,将产物真空干燥。 可以使用乙醇,丙酮或异丙醇作为有机溶剂。 或者,可以通过将增溶剂和至少一种植物营养物的粉末干混合来制备组合物。